4//SEC Filing
Chen Ruoyu 4
Accession 0001140361-26-000831
CIK 0001124105other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:01 PM ET
Size
5.5 KB
Accession
0001140361-26-000831
Insider Transaction Report
Form 4
Chen Ruoyu
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+50,000→ 50,000 totalExercise: $7.31Exp: 2036-01-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 50,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
GYRE THERAPEUTICS, INC.
CIK 0001124105
Entity typeother
Related Parties
1- filerCIK 0001982080
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:01 PM ET
- Size
- 5.5 KB